These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30685323)

  • 1. Stem cells in animal models of Huntington disease: A systematic review.
    Colpo GD; Furr Stimming E; Teixeira AL
    Mol Cell Neurosci; 2019 Mar; 95():43-50. PubMed ID: 30685323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.
    Liu L; Huang JS; Han C; Zhang GX; Xu XY; Shen Y; Li J; Jiang HY; Lin ZC; Xiong N; Wang T
    Mol Neurobiol; 2016 Dec; 53(10):6698-6708. PubMed ID: 26659595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease.
    Choi KA; Hwang I; Park HS; Oh SI; Kang S; Hong S
    Biotechnol J; 2014 Jul; 9(7):882-94. PubMed ID: 24827816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Models: HD Patient-Derived Pluripotent Stem Cells.
    Geater C; Hernandez S; Thompson L; Mattis VB
    Methods Mol Biol; 2018; 1780():41-73. PubMed ID: 29856014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory Strategies for Huntington's Disease Treatment.
    Colpo GD; Rocha NP; Stimming EF; Teixeira AL
    CNS Neurol Disord Drug Targets; 2017; 16(8):936-944. PubMed ID: 28606048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell transplantation for Huntington's diseases.
    Choi KA; Choi Y; Hong S
    Methods; 2018 Jan; 133():104-112. PubMed ID: 28867501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concise Review: The Use of Stem Cells for Understanding and Treating Huntington's Disease.
    Connor B
    Stem Cells; 2018 Feb; 36(2):146-160. PubMed ID: 29178352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell-based cell therapy for Huntington disease: a review.
    Kim M; Lee ST; Chu K; Kim SU
    Neuropathology; 2008 Feb; 28(1):1-9. PubMed ID: 18069970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington's disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number.
    Rossignol J; Fink KD; Crane AT; Davis KK; Bombard MC; Clerc S; Bavar AM; Lowrance SA; Song C; Witte S; Lescaudron L; Dunbar GL
    Stem Cell Res Ther; 2015 Feb; 6(1):9. PubMed ID: 25971780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced neural stem cells as a means of treatment in Huntington's disease.
    Choi KA; Hong S
    Expert Opin Biol Ther; 2017 Nov; 17(11):1333-1343. PubMed ID: 28792249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of cellular phenotypes in neural cells derived from Huntington's disease monkey-induced pluripotent stem cells.
    Carter RL; Chen Y; Kunkanjanawan T; Xu Y; Moran SP; Putkhao K; Yang J; Huang AH; Parnpai R; Chan AW
    Stem Cell Reports; 2014 Oct; 3(4):585-93. PubMed ID: 25358787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challenges.
    Kerkis I; Haddad MS; Valverde CW; Glosman S
    Stem Cell Res Ther; 2015 Dec; 6():232. PubMed ID: 26667114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human-to-mouse prion-like propagation of mutant huntingtin protein.
    Jeon I; Cicchetti F; Cisbani G; Lee S; Li E; Bae J; Lee N; Li L; Im W; Kim M; Kim HS; Oh SH; Kim TA; Ko JJ; Aubé B; Oueslati A; Kim YJ; Song J
    Acta Neuropathol; 2016 Oct; 132(4):577-92. PubMed ID: 27221146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of human stem cells in Huntington disease modeling and translational research.
    Golas MM; Sander B
    Exp Neurol; 2016 Apr; 278():76-90. PubMed ID: 26826449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huntington's disease and cell therapies: past, present, and future.
    Antoniades CA; Watts C
    Methods Mol Biol; 2013; 1010():19-32. PubMed ID: 23754216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
    Lescaudron L; Naveilhan P; Neveu I
    Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice.
    Reidling JC; Relaño-Ginés A; Holley SM; Ochaba J; Moore C; Fury B; Lau A; Tran AH; Yeung S; Salamati D; Zhu C; Hatami A; Cepeda C; Barry JA; Kamdjou T; King A; Coleal-Bergum D; Franich NR; LaFerla FM; Steffan JS; Blurton-Jones M; Meshul CK; Bauer G; Levine MS; Chesselet MF; Thompson LM
    Stem Cell Reports; 2018 Jan; 10(1):58-72. PubMed ID: 29233555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Overview of the Use of iPSCs Huntington's Disease Modeling and Therapy.
    Csobonyeiova M; Polak S; Danisovic L
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32213859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells.
    Jeon I; Lee N; Li JY; Park IH; Park KS; Moon J; Shim SH; Choi C; Chang DJ; Kwon J; Oh SH; Shin DA; Kim HS; Do JT; Lee DR; Kim M; Kang KS; Daley GQ; Brundin P; Song J
    Stem Cells; 2012 Sep; 30(9):2054-62. PubMed ID: 22628015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity.
    Tousley A; Kegel-Gleason KB
    J Huntingtons Dis; 2016 Jun; 5(2):99-131. PubMed ID: 27372054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.